Trial Profile
RES-ELUTION-III
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 12 Nov 2008
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms RES-ELUTION-III
- Sponsors Conor Medsystems; Cordis Corporation
- 12 Nov 2008 New trial record.